17 January 2017
News and Views
Links and Services
Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms, reports December's issue of the Alimentary Pharmacology & Therapeutics.
While rifaximin was able to improve symptoms in patients with irritable bowel syndrome (IBS) in p
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors